Thrombosis prevention by coagulation and platelet aggregtion inhibitors, in hyperlipemic rats.
D000074:Acenocoumarol / Q000494:pharmacology / Q000627:therapeutic use; D000227:Adenine Nucleotides / Q000494:pharmacology; D000814:Aniline Compounds / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D001792:Blood Platelets / Q000187:drug effects; D004357:Drug Synergism; D004731:Endotoxins / Q000494:pharmacology; D006949:Hyperlipidemias / Q000097:blood*; D010113:Oxyphenbutazone / Q000494:pharmacology / Q000627:therapeutic use; D010648:Phenylacetates / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology / Q000627:therapeutic use; D010973:Platelet Adhesiveness / Q000187:drug effects; D051381:Rats; D013442:Sulfinpyrazone / Q000494:pharmacology / Q000627:therapeutic use; D013917:Thrombin; D013927:Thrombosis / Q000139:chemically induced / Q000517:prevention & control*
D000227:Adenine Nucleotides; D000814:Aniline Compounds; D000925:Anticoagulants; D004731:Endotoxins; D010648:Phenylacetates; D013917:Thrombin; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D000074:Acenocoumarol; D013442:Sulfinpyrazone